Vericel Corp

For the period ended Dec 31, 2024. Filed Feb 27, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 27, 2025

VCEL$58.39+6.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Signatures

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date:	February 27, 2025
		Vericel Corporation
		/s/ DOMINICK C. COLANGELO
		Dominick C. Colangelo
		President and Chief Executive Officer
		(Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed on behalf of the registrant on February 27, 2025 by the following persons in the capacities indicated.

Robert L. Zerbe, M.D.
Signature	Title
/s/ DOMINICK C. COLANGELO	President and Chief Executive Officer, Director
Dominick C. Colangelo	(Principal Executive Officer)
/s/ JOSEPH A. MARA	Chief Financial Officer
Joseph A. Mara	(Principal Financial Officer)
/s/ JONATHAN D. SIEGAL	Vice President and Corporate Controller
Jonathan D. Siegal	(Principal Accounting Officer)
/s/ ROBERT L. ZERBE, M.D.	Chairman of the Board of Directors
/s/ ALAN L. RUBINO	Director
Alan L. Rubino
/s/ HEIDI M. HAGEN	Director
Heidi M. Hagen
/s/ STEVEN C. GILMAN	Director
Steven C. Gilman
/s/ KEVIN F. MCLAUGHLIN	Director
Kevin F. McLaughlin
/s/ PAUL K. WOTTON	Director
Paul K. Wotton
/s/ LISA WRIGHT	Director
Lisa Wright

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.